Problems in the treatment of premenstrual syndrome
- PMID: 2187582
- DOI: 10.1177/070674379003500301
Problems in the treatment of premenstrual syndrome
Abstract
Three categories of treatments for premenstrual syndrome (PMS) have been proposed: those designed to correct the cause of the disorder; those designed for symptom relief; and those aimed at eliminating the menstrual cycle. Many of these recommendations are based on poor research with loose definitions of the disorder and uncontrolled open trials. This paper reviews the literature on treatment methods with emphasis on recent random, placebo controlled, double-blind studies. The most effective current management of PMS is a conservative one including accurate diagnosis, stress control, sensible levels of diet and exercise and perhaps the use of alprazolam in the premenstrual period. Other approaches such as the use of mefenamic acid and evening oil of primrose remain unproven. Progesterone has been proven uneffective. Further research is required into the value of antidepressant medication.
Similar articles
-
A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.JAMA. 1995 Jul 5;274(1):51-7. JAMA. 1995. PMID: 7791258 Clinical Trial.
-
Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.Arch Gen Psychiatry. 1993 Jun;50(6):467-73. doi: 10.1001/archpsyc.1993.01820180069007. Arch Gen Psychiatry. 1993. PMID: 8498881 Clinical Trial.
-
Premenstrual syndrome: current knowledge and management.CMAJ. 1989 Mar 15;140(6):605-11. CMAJ. 1989. PMID: 2645986 Free PMC article. Review.
-
Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.Obstet Gynecol. 1987 Jul;70(1):37-43. Obstet Gynecol. 1987. PMID: 3299178 Clinical Trial.
-
Medical management of premenstrual dysphoric disorder.J Gend Specif Med. 1999 May-Jun;2(3):55-60. J Gend Specif Med. 1999. PMID: 11252853 Review.
Cited by
-
Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trial.PLoS One. 2017 Apr 18;12(4):e0175068. doi: 10.1371/journal.pone.0175068. eCollection 2017. PLoS One. 2017. PMID: 28419170 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical